Cargando…

Medicines for cancers in children: The WHO model for selection of essential medicines

Pressures to include more cancer medicines in the WHO Model List of Essential Medicines (EML) pose challenges for the Expert Committee responsible for recommending changes to the list. How do medicines for cancer fit within a definition of essential medicines as those meeting the priority health nee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robertson, Jane, Magrini, Nicola, Barr, Ronald, Forte, Gilles, Ondari, Clive
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132122/ https://www.ncbi.nlm.nih.gov/pubmed/25929524 http://dx.doi.org/10.1002/pbc.25564

Ejemplares similares

Essential medicines for cancer: WHO recommendations and national priorities
por: Robertson, Jane, et al.
Publicado: (2016)

Tough decisions on essential medicines in 2015
por: Magrini, Nicola, et al.
Publicado: (2015)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
por: Cappello, Bernadette, et al.
Publicado: (2020)

Shortages and price variability of essential cytotoxic medicines for treating children with cancers
por: Martei, Yehoda M, et al.
Publicado: (2020)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?
por: Magrini, Nicola, et al.
Publicado: (2015)

Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level
por: Todesco, B., et al.
Publicado: (2022)

Availability of WHO Essential Medicines for Cancer Treatment in Botswana
por: Martei, Yehoda M., et al.
Publicado: (2018)

Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

WHO essential medicines for reproductive health
por: Gill, Roopan, et al.
Publicado: (2019)

Revising the WHO Essential Medicines List for paediatric rheumatology update
por: Slamang, Waheba, et al.
Publicado: (2022)

Medicines availability for non-communicable diseases: the case for standardized monitoring
por: Robertson, Jane, et al.
Publicado: (2015)

Erratum to: Medicines availability for non-communicable diseases: the case for standardized monitoring
por: Robertson, Jane, et al.
Publicado: (2015)

WHO Traditional Medicine Global Summit 2023 meeting report: Gujarat Declaration
Publicado: (2023)

The economic case for precision medicine
por: Gavan, Sean P., et al.
Publicado: (2018)

Access and use of WHO essential medicines in Italy
por: Petrella, Alessandro, et al.
Publicado: (2023)

NO supplementation for transfusion medicine and cardiovascular applications
por: Cabrales, Pedro, et al.
Publicado: (2015)

Evidence of clinical benefit of WHO essential anticancer medicines for children, 2011–2021
por: Bai, Lin, et al.
Publicado: (2023)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

Small but Steady Steps in Stroke Medicine in Japan
por: Toyoda, Kazunori, et al.
Publicado: (2019)

ADVANCING ACADEMIC CAPACITY IN PHYSICAL AND REHABILITATION MEDICINE TO STRENGTHEN REHABILITATION IN HEALTH SYSTEMS WORLDWIDE: A JOINT EFFORT BY THE EUROPEAN ACADEMY OF REHABILITATION MEDICINE, THE ASSOCIATION OF ACADEMIC PHYSIATRISTS, AND THE INTERNATIONAL SOCIETY OF PHYSICAL AND REHABILITATION MEDICINE
por: FRONTERA, Walter R., et al.
Publicado: (2022)

A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
por: Naicker, Ian, et al.
Publicado: (2022)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
por: delMoral-Sanchez, Jose-Manuel, et al.
Publicado: (2020)

WHO monographs on selected medicinal plants.
Publicado: (1999)

Promoting and regulating generic medicines: Brazil in comparative perspective
por: da Fonseca, Elize Massard, et al.
Publicado: (2017)

Noncommunicable diseases, access to essential medicines and universal health coverage
por: Beran, David, et al.
Publicado: (2019)

Essential Medicinal Chemistry of Essential Medicines
por: Serafini, Marta, et al.
Publicado: (2020)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

Therapeutics and COVID‐19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine
por: Møller, Morten H., et al.
Publicado: (2022)

Origins and Evolution of Social Medicine and Contemporary Social Medicine in Korea
por: Han, Dal Sun, et al.
Publicado: (2017)

Engaging children and young people on the potential role of artificial intelligence in medicine
por: Visram, Sheena, et al.
Publicado: (2022)

Identifying the most effective essential medicines policies for quality use of medicines: A replicability study using three World Health Organisation data-sets
por: Holloway, Kathleen Anne, et al.
Publicado: (2020)

The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics
por: Holloway, Kathleen Anne, et al.
Publicado: (2016)

Mechanistic Insights on the Mechanosynthesis of Phenytoin, a WHO Essential Medicine
por: Puccetti, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_etr4nkbuvmkhhait117lg69qc3